First Horizon Advisors’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,237	Closed	-$6K	–	2481
2022 Q3	$6K	Buy	1,237 +348	+39%	+$1.69K	﹤0.01%	1702
2022 Q2	$2K	Buy	889 +833	+1,488%	+$1.87K	﹤0.01%	2092
2022 Q1	$0	Buy	+56	New	–	﹤0.01%	1970